Gold nanoparticles can spot biomarker for blood clots

04/12/2010 | MIT Technology Review

Scottish scientists have developed gold nanoparticles that enable them to measure concentrations of thrombin, a protein linked to blood clots, in blood specimens using laser light. They hope the technology leads to tests in which patients are implanted with nanosensors to help detect blood clots and other diseases.

View Full Article in:

MIT Technology Review

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI